Unsaturated fatty acids lactose esters: cytotoxicity, permeability enhancement and antimicrobial activity

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 107, Issue , 2016, Pages 88-96

  Lucarini, Simone ^a   Fagioli, Laura ^a   Campana, Raffaella ^a   Cole, Hannah ^b   Duranti, Andrea ^a   Baffone, Wally ^a   Vllasaliu, Driton ^b   Casettari, Luca ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF LINCOLN   (United Kingdom)

Author keywords

Antimicrobial agents; Lactose esters; Nervonic acid; Palmitoleic acid; Permeability enhancers; Sugar based surfactants

Indexed keywords

DISACCHARIDE; ESTER; LACTOSE; LACTOSE NERVONATE; LACTOSE PALMITOLEATE; PALMITOLEIC ACID; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; UNSATURATED FATTY ACID;

ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENTEROCOCCUS FAECALIS; ENZYME SYNTHESIS; ESCHERICHIA COLI O157; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; PERMEABILITY; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; STAPHYLOCOCCUS AUREUS; TRANSEPITHELIAL RESISTANCE; YERSINIA ENTEROCOLITICA; BACTERIUM; CACO-2 CELL LINE; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; CACO-2 CELLS; CANDIDA ALBICANS; ESTERS; FATTY ACIDS, UNSATURATED; HUMANS; LACTOSE; MICROBIAL SENSITIVITY TESTS; PERMEABILITY;

EID: 84979031748     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2016.06.022     Document Type: Article

References (32)

1. [1] Savić, S., Tamburić, S., Savić, M.M., From conventional towards new natural surfactants in drug delivery systems design: current status and perspectives. Expert Opin. Drug Deliv. 7 (2010), 353–369, 10.1517/17425240903535833.
2. [2] Neta, N.S., Teixeira, J.A., Rodrigues, L.R., Sugar ester surfactants: enzymatic synthesis and applications in food industry. Crit. Rev. Food Sci. Nutr. 55 (2015), 595–610, 10.1080/10408398.2012.667461.
3. [3] Zhao, L., Zhang, H., Hao, T., Li, S., In vitro antibacterial activities and mechanism of sugar fatty acid esters against five food-related bacteria. Food Chem. 187 (2015), 370–377, 10.1016/j.foodchem.2015.04.108.
4. [4] Nobmann, P., Smith, A., Dunne, J., Henehan, G., Bourke, P., The antimicrobial efficacy and structure activity relationship of novel carbohydrate fatty acid derivatives against Listeria spp. and food spoilage microorganisms. Int. J. Food Microbiol. 128 (2009), 440–445, 10.1016/j.ijfoodmicro.2008.10.008.
5. [5] Stubenrauch, C., Sugar surfactants – aggregation, interfacial, and adsorption phenomena. Curr. Opin. Colloid Interface Sci. 6 (2001), 160–170, 10.1016/S1359-0294(01)00080-2.
6. [6] Uchiyama, T., Sugiyama, T., Quan, Y.-S., Kotani, A., Okada, N., Fujita, T., Muranishi, S., Yamamoto, A., Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-β-D-maltopyranoside. J. Pharm. Pharmacol. 51 (1999), 1241–1250.
7. [7] Ahsan, F., Arnold, J., Meezan, E., Pillion, D.J., Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats. Pharm. Res. 18 (2001), 1742–1746, 10.1023/A:1013330815253.
8. [8] Vllasaliu, D., Casettari, L., Fowler, R., Exposito-Harris, R., Garnett, M., Illum, L., Stolnik, S., Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study. Int. J. Pharm. 430 (2012), 151–160, 10.1016/j.ijpharm.2012.04.012.
9. [9] Thanou, M., Verhoef, J.C., Junginger, H.E., Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev. 50 (2001), S91–S101, 10.1016/S0169-409X(01)00180-6.
10. [10] Di Colo, G., Zambito, Y., Zaino, C., Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. J. Pharm. Sci. 97 (2008), 1652–1680, 10.1002/jps.21043.
11. [11] Cox, D.S., Raje, S., Gao, H., Salama, N.N., Eddington, N.D., Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin. Pharm. Res. 19 (2002), 1680–1688, 10.1023/A:1020709513562.
12. [12] Aungst, B.J., Absorption enhancers: applications and advances. AAPS J. 14 (2012), 10–18, 10.1208/s12248-011-9307-4.
13. [13] Casettari, L., Illum, L., Chitosan in nasal delivery systems for therapeutic drugs. J. Controlled Release 190 (2014), 189–200, 10.1016/j.jconrel.2014.05.003.
14. [14] Perinelli, D.R., Casettari, L., Cespi, M., Fini, F., Man, D.K.W., Giorgioni, G., Canala, S., Lam, J.K.W., Bonacucina, G., Palmieri, G.F., Chemical–physical properties and cytotoxicity of N-decanoyl amino acid-based surfactants: effect of polar heads. Colloids Surf. Physicochem. Eng. Asp. 492 (2016), 38–46, 10.1016/j.colsurfa.2015.12.009.
15. [15] Shubber, S., Vllasaliu, D., Rauch, C., Jordan, F., Illum, L., Stolnik, S., Mechanism of mucosal permeability enhancement of CriticalSorb® (Solutol® HS15) investigated in vitro in cell cultures. Pharm. Res. 32 (2015), 516–527, 10.1007/s11095-014-1481-5.
16. [16] L.A.W. Thelwall, L. Hough, A.C. Richardson, Sugar Acetals, their Preparation and Use, 1981. < http://www.google.ch/patents/US4284763>.
17. [17] Schwartz, J.H., Talley, E.A., Esters of glucose and lactose. J. Am. Chem. Soc., 73, 1951, 4490.
18. [18] Scholnick, F., Sucharski, M.K., Linfield, W.M., Lactose-derived surfactants (I) fatty esters of lactose. J. Am. Oil Chem. Soc. 51 (1974), 8–11, 10.1007/BF02545205.
19. [19] Sarney, D.B., Kapeller, H., Fregapane, G., Vulfson, E.N., Chemo-enzymatic synthesis of disaccharide fatty acid esters. J. Am. Oil Chem. Soc. 71 (1994), 711–714, 10.1007/BF02541426.
20. [20] Habulin, M., Šabeder, S., Knez, Ž., Enzymatic synthesis of sugar fatty acid esters in organic solvent and in supercritical carbon dioxide and their antimicrobial activity. J. Supercrit. Fluids 45 (2008), 338–345, 10.1016/j.supflu.2008.01.002.
21. [21] Plat, T., Linhardt, R.J., Syntheses and applications of sucrose-based esters. J. Surfactants Deterg. 4 (2001), 415–421, 10.1007/s11743-001-0196-y.
22. [22] Kiss, L., Hellinger, É., Pilbat, A.-M., Kittel, Á., Tö Rök, Z., Furedi, Szakács, G., Veszelka, S., Sipos, P., Ózsvári, B.É., Puskás, L.G., Vastag, M., Szabó -RÉVÉSZ, P., Deli, M.A., Sucrose esters increase drug penetration, but do not inhibit P-glycoprotein in Caco-2 intestinal epithelial cells. J. Pharm. Sci. 103 (2014), 3107–3119, 10.1002/jps.24085.
23. [23] Szuts, A., Szabó-Révész, P., Sucrose esters as natural surfactants in drug delivery systems – a mini-review. Int. J. Pharm. 433 (2012), 1–9, 10.1016/j.ijpharm.2012.04.076.
24. [24] Vllasaliu, D., Shubber, S., Fowler, R., Garnett, M., Alexander, C., Stolnik, S., Epithelial toxicity of alkylglycoside surfactants. J. Pharm. Sci. 102:1 (2013), 114–125.
25. [25] Warisnoicharoen, W., Lansley, A.B., Lawrence, M.J., Toxicological evaluation of mixtures of nonionic surfactants, alone and in combination with oil. J. Pharm. Sci. 92 (2003), 859–868, 10.1002/jps.10335.
26. [26] Anderberg, E.K., Artursson, P., Epithelial transport of drugs in cell culture. VIII: effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 82 (1993), 392–398, 10.1002/jps.2600820412.
27. [27] Anderberg, E.K., Nyström, C., Artursson, P., Epithelial transport of drugs in cell culture. VII: effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 81 (1992), 879–887, 10.1002/jps.2600810908.
28. [28] Duizer, E., Van Der Wulp, C., Versantvoort, C.H.M., Groten, J.P., Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells. J. Pharmacol. Exp. Ther. 287 (1998), 395–402.
29. [29] Gizurarson, S., Marriott, C., Martin, G.P., Bechgaard, E., The influence of insulin and some excipients used in nasal insulin preparations on mucociliary clearance. Int. J. Pharm. 65 (1990), 243–247, 10.1016/0378-5173(90)90149-X.
30. [30] Pillion, D.J., Atchison, J.A., Gargiulo, C., Wang, R.-X., Wang, P., Meezan, E., Insulin delivery in nosedrops: new formulations containing alkylglycosides. Endocrinology 135 (1994), 2386–2391, 10.1210/en.135.6.2386.
31. [31] Petersen, S.B., Nolan, G., Maher, S., Rahbek, U.L., Guldbrandt, M., Brayden, D.J., Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers. Eur. J. Pharm. Sci. 47 (2012), 701–712, 10.1016/j.ejps.2012.08.010.
32. [32] Marçon, F., Moreau, V., Helle, F., Thiebault, N., Djedaïni-Pilard, F., Mullié, C., β-Alkylated oligomaltosides as new alternative preservatives: antimicrobial activity, cytotoxicity and preliminary investigation of their mechanism of action. J. Appl. Microbiol. 115 (2013), 977–986, 10.1111/jam.12301.